<DOC>
	<DOCNO>NCT01679340</DOCNO>
	<brief_summary>To investigate efficiency safety SOX SP adjuvant chemotherapy phase II III gastric cancer patient D2 surgery . If SOX equal SP efficiency less toxicity .</brief_summary>
	<brief_title>A PhaseⅡ Study : SOX v SP Adjuvant Chemotherapy After D2 Surgery</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologically confirm Phase III adenocarcinoma gastric esophagealgastric junction ( AJCC 7th ) without previous treatment , include radiotherapy , chemotherapy immunotherapy Hb≥90g/L , WBC 4×109/L10×109/L , ANC≥2×109/L , Platelet≥100×109/L creatinine≤1 UNL total bilirubin≤1.5 UNL , AST ( SGOT ) , ALT ( SGPT ) ALP≤2.5 UNL ECOG score 0 2 take chemotherapy 8 week surgery older 18 year follow , good compliance take medicine orally sign informed consent combine disease lead Life Expectancy le 3 year evidence show metastasis , include cancer cell peritoneal fluid inability take oral medication difficult swallow , intestinal obstruction，active intestinal blooding perforation previous treatment , include cytotoxic chemotherapy , radio chemotherapy immunotherapy ( except corticosteroid hormone） operation within 4 week , recover last major operation allergy fluorouracil allergy Platinum composition research drug uncontrollable seizure disorder，central nervous system disease mental disorder , clinical significance judgement researcher , influnce understanding inform consent compliance take orally drug past 12 month , clinical significant heart disease ( active ) , symptomatic coronary heart disease , &gt; =Stage II congestive cardiac failure ; congestive heart failure NYHA standard , serious arrhythmia need take medicine ( Appendix 10th ) , myocardical infarction . pregnancy， lactation， woman childbearing period spouse reject take effictive method conraception previous malignancy within 5 year , except heal skin basal cell carcinoma carcinoma cervix peripheral neuropathy &gt; grade 1 CTCAEv3 , except neural abnormality patient lose deep tendon reflex（DTRs） . serious complicated infection complicate disease hard controll . As one belowing : ANC &lt; 2×109/L Platelet &lt; 100×109/L total bilirubin &gt; 1.5 UNL ALAT、ASAT &gt; 2.5 x ULN ALP &gt; 2.5 x ULN Any investigational agent within past 28 day . That patient jioned another trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>D2 surgery</keyword>
	<keyword>S-1</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>cisplatin</keyword>
</DOC>